Insights
Discover how artificial intelligence in specialty pharmacy is supporting pharmacy professionals by freeing up time to focus on what matters most: patient care.
Insights
Mavacamten is a first in class myosin inhibitor used in the treatment of obstructive hypertrophic cardiomyopathy (oHCM).
News
News
Shields will support San Diego-based care group with increased access to specialty drugs and expanded insurance coverage
News
Award spotlights the company’s recent growth and continued employee retention
News
Across nearly 80 health system partners, Shields maintained high-quality care while experiencing annual growth in patient volume across diverse disease states
News
The partnership will support patients through personalized care, medications, and coordination
News
Expanded partnership to accelerate continued growth of specialty pharmacy and improve community care
News
News
News
News
The partnership will support patients through personalized care, medications, and coordination
